- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02341651
Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka, Feasibility Study (COBRA-BPS)
Feasibility Study for a Cluster Randomized Trial on Integrated Primary Care Strategies to Reduce High Blood Pressure (Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka, Feasibility Study)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The rationale for conducting the feasibility study in 3 proposed South Asian countries is strong. The South Asian countries are in a unique stage of epidemiological transition with a double burden of communicable and NCDs, the latter increasing rapidly. (2) These countries also share cultural habits and social structure with an extended family system, and have largely similar population characteristics and health seeking behaviours. (10)Moreover, the rural health system in all South Asian countries relies on cadres community health workers. At the same time there are some differences. Bangladesh and Pakistan have a high proportion of people living in extreme poverty (purchasing power parity <US $1.25/day, 49.6% and 22.6%, respectively) compared to Sri Lanka (14%) which has relatively better development indicators in terms of life expectancy and literacy rates (World Bank 2010). However age-standardized death rates from non-communicable diseases (NCDs) are uniformly high in all 3 countries. The feasibility will allow direct comparison of some of these population (individual) and health systems characteristics among countries relevant for hypertension care. Thus, data from the feasibility will inform the future design of the trial.
In order to optimize the trial design of the full study, a mixed-methods feasibility study with quasi-experimental pre- and post- evaluation of "triple approach" with all 3 components of intervention, survey of pharmacies, and focus group discussions and individual in-depth interviews to better inform the strategies for the full-scale trial in rural settings in Bangladesh, Pakistan, and Sri Lanka.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Mohakhali
-
Dhaka, Mohakhali, Bangladesh, 1212
- Initiative for Non-Communicable Diseases icddr,b
-
-
-
-
-
Karachi, Pakistan, 74800
- Aga Khan University Hospital
-
-
-
-
-
Ragama, Sri Lanka
- University of Kelaniya
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age≥ 40 years
- Residing in the selected clusters
Hypertension defined either as:
- persistently elevated BP (systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg) from each set of 2 readings from 2 separate days
- maintained on anti-hypertensive medications
- Informed consent
Exclusion Criteria:
- Bed-ridden individuals too ill to commute to the clinic
- Individuals with advanced medical disease (on dialysis, liver failure, other systemic diseases)
- Individuals that are mentally compromised and unable to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Multicomponent "combination"
Multicomponent intervention is a combination of the following 1) community health worker (CHW)- led blood pressure (BP) screening and referral to provider, plus 2) home health education (HHE) adapted to the local diet by trained CHW plus 3) trained primary health center mid-level providers (MLP) and physicians using evidence-based treatment algorithm of BP lowering in all and lipid lowering for high risk, plus 4) process-based incentives
|
Multicomponent intervention is a combination of the following 1) community health worker (CHW)- led blood pressure (BP) screening and referral to provider, plus 2) home health education (HHE) adapted to the local diet by trained CHW plus 3) trained primary health center mid-level providers (MLP) and physicians using evidence-based treatment algorithm of BP lowering in all and lipid lowering for high risk, plus 4) process-based incentives
|
|
No Intervention: Usual Care
No active intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
retention rate
Time Frame: 3 months
|
proportion of hypertensive individuals followed up at 3 months in 3 countries
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fidelity measure- Proportion of providers trained
Time Frame: 3 months
|
proportion of targeted providers trained in 3 countries
|
3 months
|
|
Fidelity measure- home health education sessions delivered
Time Frame: 3 months
|
Proportion of planned home health education sessions delivered in 3 countries
|
3 months
|
|
fidelity measure 3- physician management checklist collected
Time Frame: 3 months
|
proportion of expected physician management checklist collected
|
3 months
|
|
Baseline to follow-up change in systolic blood pressure level
Time Frame: 3 months
|
within clusters intra-class correlation (95% CI) pre- to post- intervention change in systolic
|
3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Tazeen H Jafar, MD, MPH, Duke-NUS, Singapore
- Principal Investigator: Imtiaz Jehan, Aga Khan University
- Principal Investigator: Asita de Silva, University of Kelaniya, Sri Lanka
- Principal Investigator: Shah Ebrahim, London School of Hygiene and Tropical Medicine
- Principal Investigator: Aliya Naheed, Initiative for Non-Communicable Diseases icddr,b, Bangladesh
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MR/L004224/1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.